Publication Cover
Canadian Journal of Pain
Revue canadienne de la douleur
Volume 7, 2023 - Issue 1
1,125
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Chronic Pain: A Case Application of a Novel Framework to Guide Interprofessional Assessment and Intervention in Primary Care

ORCID Icon
Article: 2228851 | Received 04 Dec 2022, Accepted 20 Jun 2023, Published online: 27 Jul 2023

References

  • Schopflocher D, Taenzer P, Jovey R. The prevalence of chronic pain in Canada. Pain Res Manage. 2011;16(6):445–9. doi:10.1155/2011/876306.
  • Henry JL. The need for knowledge translation in chronic pain. Pain Res Manage. 2008;13(6):465–76. doi:10.1155/2008/321510.
  • Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082–97. doi:10.1016/S0140-6736(21)00393-7.
  • Hassan S, Carlin L, Zhao J, Taenzer P, Furlan AD. Promoting an interprofessional approach to chronic pain management in primary care using project ECHO. J Interprof Care. 2021;35(3):464–67. doi:10.1080/13561820.2020.1733502.
  • Pearson AC, Moman RN, Moeschler SM, Eldrige JS, Hooten WM. Provider confidence in opioid prescribing and chronic pain management: results of the opioid therapy provider survey. J Pain Res. 2017;10:1395–400. doi:10.2147/JPR.S136478.
  • Walton DM, Elliott JM. A new clinical model for facilitating the development of pattern recognition skills in clinical pain assessment. Musculoskelet Sci Pract. 2018;36:17–24. doi:10.1016/j.msksp.2018.03.006.
  • Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, Agoritsas T, Akl EA, Carrasco-Labra A, Cooper L, et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ. 2017;189(18):E659–E666. doi:10.1503/cmaj.170363.
  • Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med. 2005;6(6):432–42. doi:10.1111/j.1526-4637.2005.00072.x.
  • Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore. 1994;23:129–38.
  • Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–37. doi:10.1016/j.jpsychores.2005.10.020.
  • Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524–32. doi:10.1037/1040-3590.7.4.524.
  • Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the beck depression and anxiety inventories. Behav Res Ther. 1995;33(3):335–43. doi:10.1016/0005-7967(94)00075-U.
  • Mayer TG, Neblett R, Cohen H, Howard KJ, Choi YH, Williams MJ, Perez Y, Gatchel RJ. The development and psychometric validation of the central sensitization inventory. Pain Pract. 2012;12(4):276–85. doi:10.1111/j.1533-2500.2011.00493.x.
  • Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. 2005;6(3):149–58. doi:10.1016/j.jpain.2004.11.007.
  • Miller RP, Kori SH, Todd DD. The Tampa scale: a measure of kinisophobia. Clin J Pain. 1991;7(1):51–52. doi:10.1097/00002508-199103000-00053.
  • Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14(2):145–61. doi:10.36076/ppj.2011/14/145.
  • Knoerl R, Lavoie Smith EM, Weisberg J. Chronic pain and cognitive behavioral therapy: an integrative review. West J Nurs Res. 2016;38(5):596–628. doi:10.1177/0193945915615869.
  • IsHak WW, Wen RY, Naghdechi L, Vanle B, Dang J, Knosp M, Dascal J, Marcia L, Gohar Y, Eskander L, et al. Pain and depression: a systematic review. Harv Rev Psychiatry. 2018;26(6):352–63. doi:10.1097/HRP.0000000000000198.
  • Henry SG, Paterniti DA, Feng B, Iosif A-M, Kravitz RL, Weinberg G, Cowan P, Verba S. Patients’ experience with opioid tapering: a conceptual model with recommendations for clinicians. J Pain. 2019;20(2):181–91. doi:10.1016/j.jpain.2018.09.001.
  • Moulin D, Boulanger A, Clark AJ, Clarke H, Dao T, Finley GA, Furlan A, Gilron I, Gordon A, Morley-Forster PK, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manage. 2014;19(6):328–35. doi:10.1155/2014/754693.
  • Wright A, Luedtke KE, Vandenberg C. Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy. J Pain Res. 2010;4:1–10. doi:10.2147/JPR.S12866.
  • Copay AG, Subach BR, Glassman SD, Polly DW Jr, Schuler TC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J. 2007;7(5):541–46. doi:10.1016/j.spinee.2007.01.008.
  • Williams DA, Arnold LM. Measures of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Brief Pain Inventory (BPI), Multidimensional Fatigue Inventory (MFI-20), Medical Outcomes Study (MOS) sleep scale, and Multiple Ability Self-Report Questionnaire (MASQ). Arthritis Care Res (Hoboken). 2011;63(Suppl 11(0 11)):S86–S97. doi:10.1002/acr.20531.
  • Sabourin S, Tram J, Sheldon BL, Pilitsis JG. Defining minimal clinically important differences in pain and disability outcomes of patients with chronic pain treated with spinal cord stimulation. J Neurosurg Spine. 2021;1–8. doi:10.3171/2020.11.SPINE201431.
  • Canadian Interprofessional Health Collaborative. A national interprofessional competency framework 2010. https://drive.google.com/file/d/1Des_mznc7Rr8stsEhHxl8XMjgiYWzRIn/view.